Slate Medicines | $130,000,000 | (Feb 25, 2026)
Letter AI | $40,000,000 | (Feb 25, 2026)
Subject | $28,000,000 | (Feb 25, 2026)
Roll Tack Ventures
United States
- Indianapolis, IN
- 25/02/2026
- Series A
- $6,000,000
Roll Tack Ventures is a venture capital firm based in the Midwest with global reach. The region represents an asymmetric opportunity for growth, 20% of U.S. GDP but only 3.6% of venture capital allocation. We aim to unlock this untapped potential by providing capital, local resources and global connections to the companies we back.
Roll Tack invests in B2B technologies that strengthen the mid-market corporate tech stack, enabling companies to drive growth, boost efficiency, or ensure protection. We invest once they have demonstrated product-market fit and are ready to scale (typically Series A & B).
Unlike traditional coastal capital, our deep regional expertise, robust Midwest network, and firsthand operating experience position us to back founders tackling the Midwest’s core industries, helping them scale solutions with global relevance.
👋 If you’d like to learn more, send us a note!
- Industry Venture Capital and Private Equity Principals
- Website https://rolltackventures.com/
- LinkedIn https://www.linkedin.com/company/roll-tack-ventures/
Centauri Therapeutics Limited | $8,107,170 | (Feb 25, 2026)
Slang AI | $36,000,000 | (Feb 25, 2026)
Brilliant Harvest Inc. | $4,000,000 | (Feb 25, 2026)
Koah | $20,500,000 | (Feb 25, 2026)
Nimble | $47,000,000 | (Feb 25, 2026)
General Magic | $7,200,000 | (Feb 25, 2026)
Circadian Risk Inc. | $6,000,000 | (Feb 25, 2026)
Neural Earth | $9,300,000 | (Feb 25, 2026)
Jampack AI | $3,200,000 | (Feb 25, 2026)